enalapril polpharma 20 mg tabletes
zaklady farmaceutyczne polpharma s.a., poland - enalaprila maleāts - tablete - 20 mg
apoquel
zoetis belgium sa - oklatzībīna maleāts - agents for dermatitis, excluding corticosteroids - suņi - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.
ancesol
richter pharma ag, austrija - hlorfenamīna maleāts - šķīdums injekcijām - 10 mg/ml - liellopi
killitam tablets 10 mg tabletes
fatro s.p.a., itālija - acepromazīns maleāts - tabletes - 10 mg - kaķi; suņi
killitam drops 15 mg/ml pilieni iekšķīgai lietošanai, šķīdums
fatro s.p.a., itālija - acepromazīns maleāts - pilieni iekšķīgai lietošanai, šķīdums - 15 mg/ml - kaķi; suņi
histodine
le vet beheer b.v., nīderlande - hlorfenamīna maleāts - šķīdums injekcijām - 10 mg/ml - liellopi
dorzolamide/timolol teva 20 mg/5 mg/ml acu pilieni, šķīdums
teva pharma b.v., netherlands - dorzolamidum, timololum - acu pilieni, šķīdums - 20 mg/5 mg/ml
bimatoprost/timolol sandoz 0,3 mg/5 mg/ml acu pilieni, šķīdums
sandoz d.d., slovenia - bimatoprostum, timololum - acu pilieni, šķīdums - 0,3 mg/5 mg/ml
jyseleca
gilead sciences ireland uc, galapagos nv - filgotinib maleate - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.
arutimol 5 mg/ml acu pilieni, šķīdums
bausch + lomb ireland limited, ireland - timolola maleāts - acu pilieni, šķīdums - 5 mg/ml